{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:123631",
      "entity_text" : "gefitinib",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9UJM3",
      "entity_text" : "Mig6",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "We predicted and experimentally verified that Mig6, which is a known negative regulator of EGFR and specifically expressed in H1299L858R cells, synergized with gefitinib to suppress cellular growth.",
  "reading_complete" : "2020-08-03T16:19:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:16:02Z",
  "trigger" : "synergized",
  "evidence" : [ "Mig6, which is a known negative regulator of EGFR and specifically expressed in H1299L858R cells, synergized with gefitinib" ],
  "pmc_id" : "3224393",
  "score" : 0
}